Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


Peptide and Protein Characterization with LC/MS

19 Mar 2013 - 11 Apr 2013 - Live-on-the-web



Bookmark and Share


This course provides practical, state-of-the-art approaches to protein and peptide characterization that you can immediately apply in the laboratory. We cover mass spec and protein chemistry fundamentals before diving into the specifics of MS analyzers, ionization and inlet techniques, applications, optimizing MS results and available tools and resources.

Who Should Attend:
Protein chemists new to LC/MS and experienced MS analysts new to protein analysis.

This Live-on-the-web format covers 2 days of instructions over a 4 week period. The class meets over the internet twice a week for approximately 90 minutes per session and each session is recorded. Click here to learn more and REGISTER.

Topics covered:

  • MS fundamentals plus operational specifics used in protein analysis
  • Practical advice on developing HPLC methods for LC/MS
  • Interpretation of protein mass spectra
  • Lab techniques to elucidate sequences, cystein status and post-translational modifications
  • Resources to interpret protein mass spectra and identify unknown peptides and proteins

This course is also available in Self-Paced or classroom formats. This course may also be customized for in-house presentation at your facility.



Further information
Scientific News
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Iron Regulators Join War on Pathogens
Iron regulatory proteins (IRPs) play an important role in the body’s immune system.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
Cell Machinery Wears Complex Coat
Researchers at EMBL Heidelberg have produced detailed images of the intricate protein-coats that surround trafficking vesicles - the “transport pods” that move material around within biological cells.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!